Nurse educational activity on non-prescription therapies in patients with chronic heart failure

European Journal of Cardiovascular Nursing

Volumn 6, Issue 4, 2007, Pages 314-320

  Dal Corso, Elena ^a   Bondiani, Anna Lisa ^a   Zanolla, Luisa ^a   Vassanelli, Corrado ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Heart failure therapy; Non prescription therapies; Polypharmacy

Indexed keywords

ACETYLSALICYLIC ACID; CARNITINE; DECONGESTIVE AGENT; EXPECTORANT AGENT; HERBACEOUS AGENT; MINERAL; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; VITAMIN;

ALTERNATIVE MEDICINE; ARTICLE; AYURVEDA; DRUG POTENTIATION; DRUG SAFETY; HEART FAILURE; HERBAL MEDICINE; NURSING EDUCATION; PATIENT COMPLIANCE; PATIENT EDUCATION; POLYPHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; STRUCTURED INTERVIEW;

ADULT; AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; CHRONIC DISEASE; COMPLEMENTARY THERAPIES; DRUG INTERACTIONS; DRUGS, NON-PRESCRIPTION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEART FAILURE; HUMANS; ITALY; MALE; MIDDLE AGED; NURSE CLINICIANS; NURSE'S ROLE; NURSING ASSESSMENT; NURSING METHODOLOGY RESEARCH; PATIENT EDUCATION AS TOPIC; POLYPHARMACY; QUESTIONNAIRES; RISK FACTORS; SELF ADMINISTRATION; SELF MEDICATION; SPECIALTIES, NURSING;

EID: 36448959094     PISSN: 14745151     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcnurse.2007.04.001     Document Type: Article

References (26)

1. Swedberg K., Cleland J., Dargie H., et al. For the task force for the diagnosis and treatment of chronic heart failure of the european society of cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
2. Hunt S.A., Abraham W.T., Chin M.H., et al. For the American College of Cardiology; American Heart Association task force on practice guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 112 (2005) e54-e235
3. Martínez-Sellés M., García Robles J.A., Muñoz R., Serrano J.A., Frades E., Domínguez Muñoa M., and Almendral J. Pharmacological treatment in patients with heart failure: patients knowledge and occurrence of polypharmacy, alternative medicine and immunizations. Eur J Heart Fail 6 (2004) 219-226
4. Zick S.M., Blume A., and Aaronson K.D. The prevalence and pattern of complementary and alternative supplement use in individuals with chronic heart failure. J Card Fail 8 (2005) 586-589
5. Indagine multiscopo "Condizioni di salute e ricorso ai servizi sanitari 1999-2000. ISTAT (2003) 35-79
6. I comportamenti di autocura tra benessere individuale e competitività del sistema socioeconomico. CENSIS (2005). http://www.censis.it/277/372/5357/5572/5580/5583/content.asp giugnohttp://www.censis.it/277/372/5357/5572/5580/5583/content.asp
7. Schröder D., Weiser M., and Klein P. Efficacy of a homeopathic Crataegus preparation compared with usual therapy for mild (NYHA II cardiac insufficiency: results of an observational cohort study. Eur J Heart Fail 5 (2003) 319-326
8. Zanolla L. Efficacy of a homeopathic Crataegus preparation compared with usual therapy for mild (NYHA) cardiac insufficiency: results of an observational cohort study. Eur J Heart Fail 6 (2004) 509
9. Miller L.G. Herbal medicinals. Selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 158 (1998) 2200-2211
10. Vogel J.H.K., Bolling S.F., Costello R.B., et al. Integrating complementary medicine into cardiovascular medicine. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 46 (2005) 184-221
11. Miller K.L., Liebowitz R.S., and Newby L.K. Complementary and alternative medicine in cardiovascular disease: a review of biologically based approaches. Am Heart J 147 (2004) 401-411
12. Amabile C.M., and Spencer A.P. Keeping your patient with heart failure safe. A review of potentially dangerous medications. Arch Int Med 164 (2004) 709-720
13. Page J., and Henry D. Consumption of NSAIDs and the development of congestive heart failure in elderly patients. An underrecognized public health problem. Arch Int Med 60 (2000) 777-784
14. Feenstra J., Heerdink E.R., Grobbee D.E., and Stricker B.H.C. Association of Nonsteroidal Anti-inflammatory Drugs with first occurrence of heart failure and with relapsing heart failure. The Rotterdam Study Arch Int Med 162 (2002) 265-270
15. Pilsczek F.H., Karcic A.A., and Freeman I. Case report: Dexatrim (Phenylpropanolamine) as a cause of myocardial infarction. Heart Lung 32 (2003) 100-104
16. Charatan F. Phenylpropanolamine in drugs could be a risk for stroke. Br Med J 321 (2000) 1037
17. Cantu C., Arauz A., Murillo-Bonilla L.M., Lopez M., and Barinagarrementeria F. Stroke associated with sympathomimetics contained in over-the-counter cough and cold drugs. Stroke 34 (2003) 1667-1672
18. Nozoe M., Namera A., Kohriyama K., and Takemoto. Over-the-counter medication and acute life-threatening myocardial damage. Int J Cardiol 102 (2005) 545-547
19. McAlister F.A., Lawson F.M.E., Teo K.K., and Armstrong P.W. A systematic review of randomized trials of disease management programs in heart failure. Am J Med 110 (2001) 378-384
20. Strömberg A. Educating nurses and patients to manage heart failure. Eur J Cardiovasc Nurs 1 (2002) 33-40
21. Strömberg A., Mårtensson J., Fridlund B., and Dahlström U. Nurse-led heart failure clinics in Sweden. Eur J Heart Fail 3 (2001) 139-144
22. Adams K.F., Fonarow G.C., Emerman C.L., et al., For the ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149 (2005) 209-216
23. Whellan D.J., Hasselblad V., Peterson E., O'Connor C.M., and Schulman K.A. Metaanalysis and review of heart failure disease management randomized controlled clinical trials. Am Heart J 149 (2005) 722-729
24. Winslow L.C. Herbs as medicines. Arch Int Med 158 (1998) 2192-2199
25. Isbrucker R.A., and Burdock G.A. Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul Toxicol Pharmacol 46 (2006) 167-192
26. Agenzia Italiana del Farmaco. Sorveglianza delle reazioni avverse nei prodotti a base di piante officinali. Farmacovigilanza newsletter 12/13 (2005) 3